David J. King

820 total citations
20 papers, 621 citations indexed

About

David J. King is a scholar working on Psychiatry and Mental health, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David J. King has authored 20 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David J. King's work include Schizophrenia research and treatment (8 papers), Treatment of Major Depression (3 papers) and Automotive and Human Injury Biomechanics (2 papers). David J. King is often cited by papers focused on Schizophrenia research and treatment (8 papers), Treatment of Major Depression (3 papers) and Automotive and Human Injury Biomechanics (2 papers). David J. King collaborates with scholars based in United Kingdom, United States and Switzerland. David J. King's co-authors include Denise McCartan, John R. White, Brian E. Leonard, Kathryn Griffiths, Gunter P. Siegmund, Elizabeth Wager, Stephen Cooper, Ciaran Mulholland, J. D. Merrett and Robert Bell and has published in prestigious journals such as Diabetes Care, The British Journal of Psychiatry and Psychological Medicine.

In The Last Decade

David J. King

19 papers receiving 560 citations

Peers

David J. King

PMH

CMN

PHARM

ECP

Morgan L. Levy United States

Joanna L. Iddon United Kingdom

Prashant Gajwani United States

Vinod Kumar Sinha India

Richard F. H. Catchlove Canada

Peter Häussermann Germany

Victoria C. Cambridge United Kingdom

Byungsu Kim South Korea

Spencer Wetter United States

Hans‐Peter Hundemer Germany

Morgan L. Levy United States

David J. King

667 ×2.2

PMH

263 ×1.7

114 ×0.9

CMN

99 ×1.2

PHARM

49 ×0.7

ECP

Citations per year, relative to David J. King David J. King (= 1×) peers Morgan L. Levy

Countries citing papers authored by David J. King

Since Specialization

Citations

This map shows the geographic impact of David J. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. King more than expected).

Fields of papers citing papers by David J. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. King. The network helps show where David J. King may publish in the future.

Co-authorship network of co-authors of David J. King

This figure shows the co-authorship network connecting the top 25 collaborators of David J. King. A scholar is included among the top collaborators of David J. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. King. David J. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barrett, Suzanne, et al.. (2005). Normal levels of prepulse inhibition in the euthymic phase of bipolar disorder. Psychological Medicine. 35(12). 1737–1746. 30 indexed citations

Leonard, Brian E., Denise McCartan, John R. White, & David J. King. (2004). Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Human Psychopharmacology Clinical and Experimental. 19(3). 151–180. 168 indexed citations

Mulholland, Ciaran, Gerard Lynch, David J. King, & Stephen Cooper. (2003). A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia. Journal of Psychopharmacology. 17(1). 107–112. 40 indexed citations

Johnston, Olwyn, et al.. (2002). The Efficacy of Using a Personal Stereo to Treat Auditory Hallucinations. Behavior Modification. 26(4). 537–549. 13 indexed citations

McCartan, Denise, et al.. (2001). The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers. Journal of Psychopharmacology. 15(2). 96–104. 29 indexed citations

Wheeler, Jeffrey B., et al.. (1998). Validation of the neck injury criterion (NIC) using kinematic and clinical results from human subjects in rear-end collisions. Proceedings of the International Research Council on the Biomechanics of Injury conference. 26. 335–348. 17 indexed citations

King, David J.. (1998). Drug treatment of the negative symptoms of schizophrenia. European Neuropsychopharmacology. 8(1). 33–42. 70 indexed citations

King, David J. & Elizabeth Wager. (1998). Haematological safety of antipsychotic drugs. Journal of Psychopharmacology. 12(3). 283–288. 23 indexed citations

King, David J.. (1998). Atypical antipsychotics and the negative symptoms of schizophrenia. Advances in Psychiatric Treatment. 4(1). 53–61. 7 indexed citations

10.

King, David J., et al.. (1997). Enhancement of Latent Inhibition in the Rat by the Atypical Antipsychotic Agent Remoxipride. Pharmacology Biochemistry and Behavior. 56(4). 809–816. 31 indexed citations

11.

King, David J., et al.. (1997). Guidelines for the Use of Antipsychotic Drug Studies in Healthy Volunteers. Journal of Psychopharmacology. 11(3). 201–208. 17 indexed citations

12.

King, David J., et al.. (1996). Cognitive Functioning in Schizophrenia. CNS Drugs. 6(5). 382–398. 30 indexed citations

13.

Cooper, Peter, et al.. (1996). Efficiency of Vehicle-Based Data to Predict Lane Departure Arising From Loss of Alertness Due to Fatigue. 40. 363–376. 1 indexed citations

14.

Siegmund, Gunter P., et al.. (1996). Using Barrier Impact Data to Determine Speed Change in Aligned, Low-Speed, Vehicle-to-Vehicle Collisions. SAE technical papers on CD-ROM/SAE technical paper series. 1. 29 indexed citations

15.

King, David J., et al.. (1994). Outfitting a Freightliner Tractor for Measuring Driver Fatigue and Vehicle Kinematics During Closed-Track Testing. SAE technical papers on CD-ROM/SAE technical paper series. 1. 8 indexed citations

16.

King, David J., et al.. (1993). Clozapine: the Holywell experience with the first 24 patients. Irish Journal of Psychological Medicine. 10(1). 30–34. 7 indexed citations

17.

McKane, W R, et al.. (1989). Psychomotor Performance and Counterregulatory Responses During Mild Hypoglycemia in Healthy Volunteers. Diabetes Care. 12(1). 12–17. 42 indexed citations

18.

Cooper, Stephen, Stephen Best, & David J. King. (1987). Can Psychiatric Nurses ‘Catch’ Schizophrenia?. The British Journal of Psychiatry. 151(4). 546–548. 4 indexed citations

19.

King, David J. & Kathryn Griffiths. (1984). Patterns in Drug Utilization–National and International Aspects: Psychoactive Drugs 1966–80. Acta Medica Scandinavica. 215(S683). 71–77. 14 indexed citations

20.

King, David J., et al.. (1982). Psychotropic drug use in Northern Ireland 1966–80: prescribing trends, inter- and intra-regional comparisons and relationship to demographic and socioeconomic variables. Psychological Medicine. 12(4). 819–833. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact